Otonomy Inc. (NASDAQ: OTIC) is -53.63% lower on its value in year-to-date trading and has touched a low of $1.53 and a high of $6.98 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The OTIC stock was last observed hovering at around $5.39 in the last trading session, with the day’s loss setting it -2.39% off its average median price target of $6.00 for the next 12 months. It is also 70.0% off the consensus price target high of $10.00 offered by 5 analysts, but current levels are 40.0% higher than the price target low of $5.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Currently trading at $3.00, the stock is -40.11% and -44.64% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 16.24 million and changing -44.34% at the moment leaves the stock -26.64% off its SMA200. OTIC registered -15.49% loss for a year compared to 6-month gain of -30.72%. The firm has a 50-day simple moving average (SMA 50) of $5.2353 and a 200-day simple moving average (SMA200) of $4.4871.
The stock witnessed a -36.17% loss in the last 1 month and extending the period to 3 months gives it a -30.23%, and is -42.20% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.11% over the week and 11.11% over the month.
Otonomy Inc. (OTIC) has around 56 employees, a market worth around $143.88M and $0.30M in sales. Distance from 52-week low is 96.08% and -57.04% from its 52-week high. The company has generated returns on investments over the last 12 months (-53.40%).
Otonomy Inc. (OTIC) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Otonomy Inc. (OTIC) is a “Buy”. 5 analysts offering their recommendations for the stock have an average rating of 1.80, where 0 rate it as a Hold and 0 think it is a “Overweight”. 5 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Otonomy Inc. is expected to release its quarterly report on 05/10/2021 and quarterly earnings per share for the current quarter are estimated at -$0.21 with sales reaching $30k over the same period.The EPS is expected to grow by 24.70% this year, but quarterly earnings will post 665.60% year-over-year.
Otonomy Inc. (OTIC) Top Institutional Holders
74 institutions hold shares in Otonomy Inc. (OTIC), with 118.86k shares held by insiders accounting for 0.25% while institutional investors hold 77.40% of the company’s shares. The shares outstanding are 52.34M, and float is at 48.20M with Short Float at 3.06%. Institutions hold 77.21% of the Float.
The top institutional shareholder in the company is Federated Hermes, Inc. with over 3.93 million shares valued at $15.92 million. The investor’s holdings represent 8.15% of the OTIC Shares outstanding. As of Sep 29, 2020, the second largest holder is Orbimed Advisors LLC. with 3.25 million shares valued at $13.16 million to account for 6.74% of the shares outstanding. The other top investors are Cormorant Asset Management, LP which holds 3.24 million shares representing 6.72% and valued at over $13.13 million, while Point72 Asset Management, L.P. holds 6.60% of the shares totaling 3.18 million with a market value of $12.9 million.
Otonomy Inc. (OTIC) Insider Activity
A total of 0 insider transactions have happened at Otonomy Inc. (OTIC) in the last six months, with sales accounting for 0 and purchases happening 0 times.
Otonomy Inc. (OTIC): Who are the competitors?
The company’s main competitors (and peers) include Applied Genetic Technologies Corporation (AGTC) that is trading 16.64% up over the past 12 months. Short interest in the company’s stock has risen 33.74% from the last report on Dec 30, 2020 to stand at a total of 0.97 million short shares sold with a short interest ratio of 2.38.